Pacific Pharma (Korea)


AA Medical
Concise Prescribing Info
Upper resp tract infections eg, tonsilitis, peritonsillar abscess, pharyngitis, laryngitis, sinusitis, secondary infections (influenza & common colds); lower resp tract infections eg, tonsilitis, acute & chronic bronchitis, pneumonia (lobar & primary atypical pneumonia, bronchopneumonia), bronchiectasis, Legionnaire's disease; ear infection eg, otitis media & externa mastoiditis; oral infections eg, gingivitis, Vincent's angina; ear infection eg, blepharitis; skin & soft tissue infection eg, boils & carbuncles, paronychia, abscesses, pustular acne, impetigo, cellulitis, erysipelas; GI infections eg, cholecystitis, staphylococcal enterocolitis. Pre- & post-op prophylaxis; operative trauma, burns, rheumatic fever. Other infections eg, osteomyelitis, urethritis, gonorrhea, syphilis, lymphogranuloma venereum, diphtheria, prostatitis, scarlet fever.
Dosage/Direction for Use
Adult & older childn Usual dose: 1 tab 4-6 hrly, increased to 4 g/day in unusually severe infections.
May be taken with or without food.
Hypersensitivity. Concurrent use w/ astemizole, terfenadine, cisapride or pimozide. Concomitant use w/ ergotamine & dihydroergotamine.
Special Precautions
Patients w/ myasthenia gravis. Interferes w/ fluorometric determination of urinary catecholamines. Concomitant use w/ lovastatin. Hepatic impairment.
Adverse Reactions
Nausea, abdominal discomfort, vomiting & diarrhea, reversible hearing loss, erythema multiforme.
Drug Interactions
Enhanced risk of cardiotoxicity, serious CV events (Torsades de pointes, other ventricular arrhythmias & cardiac arrest). Concomitant use w/ terfenadine may lead to death. Elevated levels of cisapride, pimozide & clarithromycin may result in QT prolongation & cardiac arrhythmias including ventricular tachycardia & fibrillation, Torsades de pointes. Acute ergot toxicity characterized by development of severe peripheral vasospasm & dysaesthesia has been associated w/ ergotamine & dihydroergotamine. Rhabdomyolysis w/ or w/o renal impairment w/ lovastatin.
MIMS Class
ATC Classification
J01FA01 - erythromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Erythropac FC tab 250 mg
10 × 10's
Erythropac FC tab 500 mg
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in